Growth Metrics

Novavax (NVAX) Notes Payables (2016 - 2022)

Novavax has reported Notes Payables over the past 8 years, most recently at $324.9 million for Q4 2022.

  • Quarterly results put Notes Payables at $324.9 million for Q4 2022, changed N/A from a year ago — trailing twelve months through Dec 2022 was $324.9 million (changed N/A YoY), and the annual figure for FY2022 was $324.9 million, changed.
  • Notes Payables for Q4 2022 was $324.9 million at Novavax, roughly flat from $324.5 million in the prior quarter.
  • Over the last five years, Notes Payables for NVAX hit a ceiling of $324.9 million in Q4 2022 and a floor of $323.8 million in Q1 2022.